Clinical Trials Browser

Phase 2 × Recurrence × Surveys and Questionnaires × Clear all

NCT02514252 2021-05-18

Sublingual Fentanyl for the Management of Breakthrough Pain

Phase 2 Terminated

6 enrolled 8 charts

Agnosia, Neoplasm Metastasis, Recurrence

NCT01782976 2018-01-19

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

Phase 2 Withdrawn

Glioblastoma, Recurrence

NCT01518140 2013-08-13

BiPAP-Vapotherm RCT

Phase 2 Withdrawn

Dyspnea, Neoplasm Metastasis, Recurrence